Josh Weiner

Investment analysts at Morgan Stanley have officially adjusted their financial outlook for Arrowhead Pharmaceuticals by lowering the firm’s price target. The revision

by

Josh Weiner

2 months ago

Recent News

Homeowners Face Financial Stress as Heating Engineers Charge Twice for Unfinished Repairs

The arrival of winter often brings a sense of dread for homeowners dealing with aging heating systems. However, the technical failure of

by

Josh Weiner

2 months ago

Support independent economical
and political view journalism

Progressive Corporation Dominates Competitors as Insurance Tech Investments Finally Pay Massive Dividends

Young Professionals Face Growing Anxiety Over Uncertain Career Paths and Financial Stability

Goldman Sachs Analysts Predict Massive Surge for Eli Lilly as Growth Trajectory Accelerates

Housing Market Data Reveals Why Home Ownership Is Now Practically Out Of Reach

How Toxic Adults Are Destroying The Spirit Of Modern Youth Sports Competition

Jim Cramer Praises United Parcel Service For Its Remarkable Stability In Shifting Markets

Hidden Expenses After Leaving The Car Dealership Are Hurting American Household Budgets

Persistent Economic Anxiety Forces American Families to Rethink the Traditional Pursuit of Prosperity

Morgan Stanley Analysts Trim Arrowhead Pharmaceuticals Price Target as Market Expectations Shift

Homeowners Face Financial Stress as Heating Engineers Charge Twice for Unfinished Repairs

Sponsored Content

Support independent economical and political view journalism

Josh Weiner

Sponsored Content

Support independent economical
and political view journalism